Literature DB >> 30025657

Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients.

Irene Marzona1, Marco Proietti2, Alessio Farcomeni3, Giulio Francesco Romiti4, Imma Romanazzi5, Valeria Raparelli6, Stefania Basili4, Gregory Y H Lip7, Alessandro Nobili8, Maria Carla Roncaglioni9.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is the most commonly diagnosed arrhythmia, which is associated with an increased risk of stroke. Several studies have suggested that female AF patients could have a greater risk for stroke and thromboembolic events (TE).
METHODS: A systematic literature review update and meta-analysis was conducted using Pubmed. The search used the terms "atrial fibrillation", "gender", "sex", "female", "women", "stroke", "thromboembolism". Main aim of the study was to compare and male AF patients for occurrence of stroke and TE. Secondary outcomes were: major bleeding, cardiovascular (CV) death and all-cause death.
RESULTS: Forty-four studies were included in the analysis including 993,603 patients (48.9% women). After pooling the data, there was a higher risk of stroke for women vs. male AF patients (hazard ratio [HR]: 1.24; 95% confidence intervals [CIs]: 1.14-1.36). Overall, TE risk was not different between female and male patients, despite sensitivity analysis left some uncertainties. No sex differences were found for major bleeding, CV death and all-cause death. A significant relationship between increasing age and the difference in stroke risk between female and male AF patients was found (Delta HR: 1.01; 95% CI: 1.00-1.03 for each year of age increase).
CONCLUSIONS: Female patients with AF are at increased risk of stroke compared to men. A significant relationship between increasing age and stroke risk in women compared to men was found, most evident at age > 65 years. Female sex may act as a stroke risk modifier, particularly in elderly and very elderly AF subjects, conferring a significant increase in stroke risk.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Outcomes; Sex; Stroke; Women

Mesh:

Substances:

Year:  2018        PMID: 30025657     DOI: 10.1016/j.ijcard.2018.07.044

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  14 in total

Review 1.  Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review.

Authors:  Leslie Cho; Melinda Davis; Islam Elgendy; Kelly Epps; Kathryn J Lindley; Puja K Mehta; Erin D Michos; Margo Minissian; Carl Pepine; Viola Vaccarino; Annabelle Santos Volgman
Journal:  J Am Coll Cardiol       Date:  2020-05-26       Impact factor: 24.094

2.  Effects of Interleukin-17A on the Early Stages of Arterial Thrombosis in Mice.

Authors:  Youngseon Park; Yeseul Shim; Il Kwon; Heow Won Lee; Hyo Suk Nam; Hyun-Jung Choi; Ji Hoe Heo
Journal:  Yonsei Med J       Date:  2022-07       Impact factor: 3.052

Review 3.  Management of atrial fibrillation: two decades of progress - a scientific statement from the European Cardiac Arrhythmia Society.

Authors:  Samuel Lévy; Gerhard Steinbeck; Luca Santini; Michael Nabauer; Diego Penela Maceda; Bharat K Kantharia; Sanjeev Saksena; Riccardo Cappato
Journal:  J Interv Card Electrophysiol       Date:  2022-04-13       Impact factor: 1.759

Review 4.  Women and atrial fibrillation.

Authors:  Annabelle Santos Volgman; Emelia J Benjamin; Anne B Curtis; Margaret C Fang; Kathryn J Lindley; Gerald V Naccarelli; Carl J Pepine; Odayme Quesada; Marmar Vaseghi; Albert L Waldo; Nanette K Wenger; Andrea M Russo
Journal:  J Cardiovasc Electrophysiol       Date:  2020-12-29       Impact factor: 2.942

Review 5.  Sex-Specific Cut-Offs for High-Sensitivity Cardiac Troponin: Is Less More?

Authors:  Giulio Francesco Romiti; Roberto Cangemi; Filippo Toriello; Eleonora Ruscio; Susanna Sciomer; Federica Moscucci; Marianna Vincenti; Clara Crescioli; Marco Proietti; Stefania Basili; Valeria Raparelli
Journal:  Cardiovasc Ther       Date:  2019-02-05       Impact factor: 3.023

6.  Prospective study of hemoglobin A1c and incident carotid artery plaque in Chinese adults without diabetes.

Authors:  Renying Xu; Ting Zhang; Yanping Wan; Zhuping Fan; Xiang Gao
Journal:  Cardiovasc Diabetol       Date:  2019-11-14       Impact factor: 9.951

7.  Influence of gender on the clinical outcomes of Asian non-valvular atrial fibrillation patients: insights from the prospective multicentre COOL-AF registry.

Authors:  Rungroj Krittayaphong; Arintaya Phrommintikul; Arjbordin Winijkul; Komsing Methavigul; Chulalak Komoltri; Pontawee Kaewkumdee; Ahthit Yindeengam
Journal:  BMJ Open       Date:  2021-05-06       Impact factor: 2.692

8.  The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials).

Authors:  David S Eccleston; Joseph M Kim; Jurien M Ten Berg; P Gabriel Steg; Deepak L Bhatt; Stefan H Hohnloser; Anne de Veer; Matias Nordaby; Corinna Miede; Takeshi Kimura; Gregory Y H Lip; Jonas Oldgren; Christopher P Cannon
Journal:  Clin Cardiol       Date:  2021-05-27       Impact factor: 2.882

9.  Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication.

Authors:  Diana M Rydberg; Marie Linder; Rickard E Malmström; Morten Andersen
Journal:  Eur J Clin Pharmacol       Date:  2020-03-28       Impact factor: 2.953

10.  Gender-Related Determinants of Adherence to the Mediterranean Diet in Adults with Ischemic Heart Disease.

Authors:  Valeria Raparelli; Giulio Francesco Romiti; Valeria Spugnardi; Marco Borgi; Roberto Cangemi; Stefania Basili; Marco Proietti
Journal:  Nutrients       Date:  2020-03-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.